Cerus - 22 Year Stock Price History | CERS

Historical daily share price chart and data for Cerus since 1997 adjusted for splits. The latest closing stock price for Cerus as of May 24, 2019 is 5.19.
  • The all-time high Cerus stock price is 80.50, which is 1451.1% above the current share price.
  • The Cerus 52-week high stock price is 7.78, which is 49.9% above the current share price.
  • The Cerus 52-week low stock price is 4.89, which is 5.8% below the current share price.
  • The average Cerus stock price for the last 52 weeks is 6.36.
Cerus Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 6.0264 5.3400 6.8500 5.1100 5.1900 2.37%
2018 5.9496 3.5600 7.7800 3.5600 5.0700 50.00%
2017 3.3151 4.3300 4.6100 2.0200 3.3800 -22.30%
2016 5.8151 6.2400 7.3900 4.2200 4.3500 -31.17%
2015 5.0900 6.5150 6.5900 3.8600 6.3200 1.28%
2014 4.7555 6.4800 7.9500 3.5000 6.2400 -3.26%
2013 5.0364 3.1900 6.9400 2.9500 6.4500 104.11%
2012 3.3740 2.8600 4.3200 2.7600 3.1600 12.86%
2011 2.7593 2.4800 3.5700 1.9800 2.8000 13.82%
2010 2.8919 1.8000 3.9300 1.7800 2.4600 23.62%
2009 1.4225 0.8200 2.9800 0.6200 1.9900 184.29%
2008 4.3830 6.5600 7.2400 0.5800 0.7000 -89.25%
2007 6.9439 5.6800 10.1800 5.1300 6.5100 11.09%
2006 7.9441 10.0100 14.4800 5.3100 5.8600 -42.27%
2005 5.7493 3.1000 11.3300 3.0500 10.1500 244.07%
2004 2.9397 4.5000 4.7100 1.8500 2.9500 -35.02%
2003 7.4819 21.7200 21.7200 3.4000 4.5400 -78.88%
2002 33.4212 46.7700 58.6800 11.8700 21.5000 -53.01%
2001 55.9461 69.7500 75.3500 33.6300 45.7500 -39.20%
2000 49.3281 24.8800 80.5000 24.8800 75.2500 183.96%
1999 23.9083 20.5000 31.2500 15.4400 26.5000 26.19%
1998 16.4552 22.0000 23.7500 12.0000 21.0000 -4.55%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.715B $0.061B
Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $135.807B 26.36
Medtronic (MDT) Ireland $124.767B 17.82
Stryker (SYK) United States $68.939B 24.60
Boston Scientific (BSX) United States $53.498B 25.65
Baxter (BAX) United States $38.314B 24.15
Zimmer Biomet Holdings (ZBH) United States $23.453B 15.07
Smith & Nephew SNATS (SNN) United Kingdom $18.518B 0.00
ResMed (RMD) United States $16.331B 31.20
Canopy Growth (CGC) Canada $15.286B 0.00
Bio-Rad Laboratories (BIO) United States $8.742B 46.35
Aurora Cannabis (ACB) Canada $8.427B 83.10
Hill-Rom Holdings (HRC) United States $6.498B 19.70
Insulet (PODD) United States $6.479B 472.04
Perrigo (PRGO) Ireland $6.439B 10.89
GW Pharmaceuticals (GWPH) United Kingdom $5.538B 0.00
Haemonetics (HAE) United States $5.172B 42.26
ICU Medical (ICUI) United States $4.652B 27.76
Hutchison China MediTech (HCM) China $3.574B 0.00
NuVasive (NUVA) United States $3.193B 26.07
Neogen (NEOG) United States $2.974B 48.36
Agios Pharmaceuticals (AGIO) United States $2.838B 0.00
National Vision Holdings (EYE) United States $2.257B 48.10
Quidel (QDEL) United States $2.184B 22.66
Aphria (APHA) $1.843B 0.00
HEXO (HEXO) $1.429B 0.00
Cardiovascular Systems (CSII) United States $1.376B 790.40
Phibro Animal Health (PAHC) United States $1.203B 18.02
AtriCure (ATRC) United States $1.140B 0.00
VAREX IMAGING (VREX) United States $1.042B 22.11
NanoString Technologies (NSTG) United States $0.973B 0.00
Lantheus Holdings (LNTH) United States $0.960B 25.49
MacroGenics (MGNX) United States $0.920B 0.00
Omeros (OMER) United States $0.876B 0.00
PetIQ (PETQ) United States $0.779B 18.92
Eagle Pharmaceuticals (EGRX) United States $0.756B 21.21
TG Therapeutics (TGTX) United States $0.633B 0.00
Surmodics (SRDX) United States $0.572B 83.22
LeMaitre Vascular (LMAT) United States $0.524B 25.35
OraSure Technologies (OSUR) United States $0.509B 23.46
Quanterix (QTRX) United States $0.505B 0.00
Meridian Bioscience (VIVO) United States $0.477B 14.57
Evolus (EOLS) United States $0.440B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.336B 0.00
BioLife Solutions (BLFS) United States $0.330B 103.12
Utah Medical Products (UTMD) United States $0.302B 20.93
Vapotherm (VAPO) United States $0.284B 0.00
Rockwell Medical (RMTI) United States $0.272B 0.00
Zynex (ZYXI) United States $0.230B 23.80
Owens & Minor (OMI) United States $0.219B 4.64
Cytosorbents (CTSO) United States $0.213B 0.00
Bovie Medical (APYX) United States $0.198B 0.00
Chimerix (CMRX) United States $0.184B 0.00
Fonar (FONR) United States $0.130B 6.83
Chembio Diagnostics (CEMI) United States $0.120B 0.00
BRAINSWAY LTD (BWAY) Israel $0.118B 0.00
Female Health (VERU) United States $0.112B 0.00
Surface Oncology (SURF) United States $0.107B 0.00
InfuSystems Holdings (INFU) United States $0.099B 0.00
United-Guardian (UG) United States $0.091B 20.10
Neurotrope (NTRP) United States $0.091B 0.00
Insys Therapeutics (INSY) United States $0.066B 0.00
Trinity Biotech (TRIB) Ireland $0.056B 19.33
Oramed Pharmaceuticals (ORMP) United States $0.051B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
Senestech (SNES) United States $0.039B 0.00
GUARDION HEALTH (GHSI) United States $0.036B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.028B 0.00
Myomo (MYO) United States $0.015B 0.00
Valeritas Holdings (VLRX) United States $0.012B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Akers Biosciences Inc (AKER) United States $0.008B 0.00
NeuroMetrix (NURO) United States $0.006B 4.57